Followers | 44 |
Posts | 3169 |
Boards Moderated | 2 |
Alias Born | 01/18/2016 |
Wednesday, November 15, 2023 7:44:59 AM
Hopefully, the Clinical Updates PR will give the push to finally complete enrollment of the 12 adult female Rett patients needed for the trial.
I'm guessing reluctance to enroll has been based on the one-time injection into the intrathecal space (directly into the Cerebral Spinal Fluid).
It's definitely worth the risk, IMO. Good Luck to All.
All my postings are verified and approved by my dog.
Recent TSHA News
- Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14 • GlobeNewswire Inc. • 05/07/2024 08:05:00 PM
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/03/2024 08:05:00 PM
- Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome • GlobeNewswire Inc. • 05/02/2024 12:00:00 PM
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/05/2024 12:00:00 PM
- Another Biotech Steals The Show Following Major Clinical Data Release • AllPennyStocks.com • 03/20/2024 05:30:00 PM
- Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical Updates • GlobeNewswire Inc. • 03/19/2024 08:01:00 PM
- US Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices Retreat • IH Market News • 03/19/2024 11:27:29 AM
- Taysha Gene Therapies to Release Full-Year 2023 Financial Results, Provide Corporate and Clinical Updates and Host Conference Call on March 19 • GlobeNewswire Inc. • 03/14/2024 08:26:51 PM
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/01/2024 10:08:33 PM
- Taysha Gene Therapies Announces Updates to TSHA-102 Clinical Program in Rett Syndrome • GlobeNewswire Inc. • 02/29/2024 01:00:00 PM
- Taysha Gene Therapies Provides Update on Deprioritized Pipeline Programs • GlobeNewswire Inc. • 02/15/2024 09:01:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/09/2024 09:24:55 PM
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/02/2024 01:00:00 PM
- Taysha Gene Therapies Announces Poster Presentation on TSHA-102 in Rett Syndrome at Upcoming British Paediatric Neurology Association 2024 Annual Conference • GlobeNewswire Inc. • 01/22/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 01:06:30 PM
- Taysha Gene Therapies Announces First Pediatric Patient Dosed with TSHA-102 in REVEAL Phase 1/2 Pediatric Trial in Rett Syndrome • GlobeNewswire Inc. • 01/10/2024 01:00:00 PM
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 01/05/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:21:59 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 12/20/2023 09:20:20 PM
- Trinity Capital Inc. Provides $40 Million Term Loan to Taysha Gene Therapies • PR Newswire (US) • 12/19/2023 12:30:00 PM
- Taysha Gene Therapies Announces Expanded Eligibility in REVEAL Phase 1/2 Adult Trial to Include Adolescent Rett Syndrome Patients • GlobeNewswire Inc. • 11/29/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 09:29:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 09:47:00 PM
- Taysha Gene Therapies Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates • GlobeNewswire Inc. • 11/14/2023 09:08:01 PM
- Taysha Gene Therapies to Release Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 14 • GlobeNewswire Inc. • 11/07/2023 01:00:00 PM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM